SML
28/04/2015 17:44
GENERAL
NOT PRICE SENSITIVE
REL: 1744 HRS Synlait Milk Limited (NS)
GENERAL: SML: Synlait Milk ingredient to significantly enhance sleep
Synlait Milk has commercialised a dairy-based milk powder ingredient that is
clinically proven to enhance sleep.
Results from an independent clinical trial of iNdream3 have proved its
efficacy as a sleep promoting ingredient.
iNdream3 is made from melatonin-rich milk collected in the hours of darkness,
when cows naturally produce increased concentrations of melatonin in their
milk.
Melatonin is a sleep-promoting hormone that plays a key role in helping
humans to regulate their day/night cycle.
iNdream3 has initially been sold in Korea by a Synlait customer since January
2015. Their product, Sleepiz, is sold as a powder in a sachet that consumers
reconstitute as a drink.
The clinical trial, conducted by Otago University's WellSleep Centre, found
that iNdream3 reduces the time to onset of sleep, increases stage N3 sleep
time (the deepest phase of sleep) and reduces daytime dysfunction. Daytime
dysfunctions include sleepiness, fatigue, impaired memory and poor
concentration.
Development of this product was funded by Synlait with additional support
from DairyNZ through the Transforming the Dairy Value Chain Primary Growth
Partnership programme.
The clinical trial was conducted by Otago University and jointly funded by
Synlait, New Zealand Trade and Enterprise (NZTE) and Ingredia SA.
ENDS
For more information please contact:
Dan Walraven
Communications Advisor, Synlait Milk
P: +64 27 836 7532 E: [email protected]
www.synlait.com
End CA:00263619 For:SML Type:GENERAL Time:2015-04-28 17:44:33
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
